<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Vet Intern Med</journal-id><journal-id journal-id-type="iso-abbrev">J. Vet. Intern. Med</journal-id><journal-id journal-id-type="doi">10.1111/(ISSN)1939-1676</journal-id><journal-id journal-id-type="publisher-id">JVIM</journal-id><journal-title-group><journal-title>Journal of Veterinary Internal Medicine</journal-title></journal-title-group><issn pub-type="ppub">0891-6640</issn><issn pub-type="epub">1939-1676</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29572937</article-id><article-id pub-id-type="pmc">5980378</article-id><article-id pub-id-type="doi">10.1111/jvim.15094</article-id><article-id pub-id-type="publisher-id">JVIM15094</article-id><article-categories><subj-group subj-group-type="overline"><subject>Standard Article</subject></subj-group><subj-group subj-group-type="heading"><subject>FOOD AND FIBER ANIMAL</subject><subj-group subj-group-type="heading"><subject>Standard Articles</subject><subj-group subj-group-type="heading"><subject>Endocrinology</subject></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Suitability of oral administration of monosodium phosphate, disodium phosphate, and magnesium phosphate for the rapid correction of hypophosphatemia in cattle</article-title><alt-title alt-title-type="left-running-head">COHRS and GR&#x000dc;NBERG</alt-title></title-group><contrib-group><contrib id="jvim15094-cr-0001" contrib-type="author" corresp="yes"><name><surname>Cohrs</surname><given-names>Imke</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9966-244X</contrib-id><address><email>ImkeCohrs@gmx.de</email></address><xref ref-type="aff" rid="jvim15094-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jvim15094-cr-0002" contrib-type="author"><name><surname>Gr&#x000fc;nberg</surname><given-names>Walter</given-names></name><xref ref-type="aff" rid="jvim15094-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="jvim15094-aff-0002">
<sup>2</sup>
</xref></contrib></contrib-group><aff id="jvim15094-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Clinic for Cattle</named-content>
<institution>University of Veterinary Medicine Hannover, Foundation</institution>
<named-content content-type="city">Hanover</named-content>
<country country="DE">Germany</country>
</aff><aff id="jvim15094-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Department of Farm Animal Health</named-content>
<institution>Utrecht University</institution>
<named-content content-type="city">Utrecht</named-content>
<country country="NL">The Netherlands</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold> Imke Cohrs, Clinic for Cattle, University of Veterinary Medicine Hannover, Foundation, Bischofsholer Damm 15, D&#x02010;30173 Hanover, Germany. Email: <email>ImkeCohrs@gmx.de</email></corresp></author-notes><pub-date pub-type="epub"><day>23</day><month>3</month><year>2018</year></pub-date><pub-date pub-type="ppub"><season>May-Jun</season><year>2018</year></pub-date><volume>32</volume><issue>3</issue><issue-id pub-id-type="doi">10.1111/jvim.2018.32.issue-3</issue-id><fpage>1253</fpage><lpage>1258</lpage><history><date date-type="received"><day>13</day><month>10</month><year>2017</year></date><date date-type="rev-recd"><day>30</day><month>11</month><year>2017</year></date><date date-type="accepted"><day>13</day><month>2</month><year>2018</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2018 American College of Veterinary Internal Medicine <copyright-statement>--><copyright-statement content-type="article-copyright">Copyright &#x000a9; 2018 The Authors. Journal of Veterinary Internal Medicine published by Wiley Periodicals, Inc. on behalf of the American College of Veterinary Internal Medicine.</copyright-statement><license license-type="creativeCommonsBy-nc"><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="file:JVIM-32-1253.pdf"/><abstract><sec id="jvim15094-sec-0001"><title>Background</title><p>Hypophosphatemia is commonly associated with disease and decreased productivity in dairy cows particularly in early lactation. Oral supplementation with phosphate salts is recognized as suitable for the rapid correction of hypophosphatemia. Little information is available about the differences in efficacy between salts used for oral phosphorus supplementation.</p></sec><sec id="jvim15094-sec-0002"><title>Objectives</title><p>Comparison of efficacy of oral administration of NaH<sub>2</sub>PO<sub>4</sub>, Na<sub>2</sub>HPO<sub>4</sub>, and MgHPO<sub>4</sub> in treating hypophosphatemia in cattle.</p></sec><sec id="jvim15094-sec-0003"><title>Animals</title><p>12 healthy dairy cows in the fourth week of lactation in their second to fifth lactation.</p></sec><sec id="jvim15094-sec-0004"><title>Methods</title><p>Randomized clinical study. Phosphorus deficient, hypophosphatemic cows underwent a sham treatment and were afterwards assigned to 1 of 3 treatments&#x02014;NaH<sub>2</sub>PO<sub>4</sub>, Na<sub>2</sub>HPO<sub>4</sub>, or MgHPO<sub>4</sub> (each provided the equivalent of 60 g of phosphorus). Blood samples were obtained immediately before and repeatedly after treatment.</p></sec><sec id="jvim15094-sec-0005"><title>Results</title><p>Treatment with NaH<sub>2</sub>PO<sub>4</sub> and Na<sub>2</sub>HPO<sub>4</sub> resulted in rapid and sustained increases of plasma phosphate concentrations ([Pi]). Significant effects were apparent within 1 hour (NaH<sub>2</sub>PO<sub>4</sub>: <italic>P =</italic> .0044; Na<sub>2</sub>HPO<sub>4</sub>: <italic>P =</italic> .0077). Peak increments of plasma [Pi] of 5.33 mg/dL [5.26&#x02013;5.36] and 4.30 mg/dL [3.59&#x02013;4.68] (median and interquartile range) were reached after 7 and 6 hours in animals treated with NaPH<sub>2</sub>PO<sub>4</sub> and Na<sub>2</sub>HPO<sub>4</sub>, respectively, whereas treatment with MgHPO<sub>4</sub> led to peak increments 14 hours after treatment (3.19 mg/dL [2.11&#x02013;4.04]).</p></sec><sec id="jvim15094-sec-1005"><title>Conclusions and Clinical Importance</title><p>NaH<sub>2</sub>PO<sub>4</sub> and Na<sub>2</sub>HPO<sub>4</sub> are suitable to rapidly correct hypophosphatemia in cattle. Because of the protracted and weaker effect, MgHPO<sub>4</sub> cannot be recommended for this purpose. Despite important differences in solubility of NaH<sub>2</sub>PO<sub>4</sub> and Na<sub>2</sub>HPO<sub>4</sub> only small plasma [Pi] differences were observed after treatment.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="jvim15094-kwd-0001">dairy cow</kwd><kwd id="jvim15094-kwd-0002">hypophosphatemia</kwd><kwd id="jvim15094-kwd-0003">magnesium phosphate</kwd><kwd id="jvim15094-kwd-0004">oral</kwd><kwd id="jvim15094-kwd-0005">sodium phosphate</kwd><kwd id="jvim15094-kwd-0006">treatment</kwd></kwd-group><funding-group><award-group><funding-source>ZuivelNL, the Netherlands
</funding-source></award-group></funding-group><counts><fig-count count="2"/><table-count count="2"/><page-count count="6"/><word-count count="4470"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>component-id</meta-name><meta-value>jvim15094</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>May/June 2018</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.4.0 mode:remove_FC converted:31.05.2018</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="jvim15094-cit-0001">
<string-name>
<surname>Cohrs</surname>
<given-names>I</given-names>
</string-name>, 
<string-name>
<surname>Gr&#x000fc;nberg</surname>
<given-names>W</given-names>
</string-name>. <article-title>Suitability of oral administration of monosodium phosphate, disodium phosphate, and magnesium phosphate for the rapid correction of hypophosphatemia in cattle</article-title>. <source xml:lang="en">J Vet Intern Med</source>. <year>2018</year>;<volume>32</volume>:<fpage>1253</fpage>&#x02013;<lpage>1258</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/jvim.15094">https://doi.org/10.1111/jvim.15094</ext-link>
</mixed-citation>
</p><fn-group><fn id="jvim15094-note-0001"><p>
<bold>Funding information</bold> ZuivelNL, the Netherlands</p></fn></fn-group></notes></front><body><def-list list-content="abbreviations" id="jvim15094-lp-0001"><title>Abbreviations</title><def-item><term id="jvim15094-li-0001">AUC&#x02010;Pi</term><def id="jvim15094-li-0002"><p>area under the concentration&#x02010;time curve of plasma phosphate</p></def></def-item><def-item><term id="jvim15094-li-0003">C</term><def id="jvim15094-li-0004"><p>CONTROL (denomination of treatment group)</p></def></def-item><def-item><term id="jvim15094-li-0005">[Ca]</term><def id="jvim15094-li-0006"><p>concentration of calcium</p></def></def-item><def-item><term id="jvim15094-li-0007">[Mg]</term><def id="jvim15094-li-0008"><p>concentration of magnesium</p></def></def-item><def-item><term id="jvim15094-li-0009">MgP</term><def id="jvim15094-li-0010"><p>group treated with MgHPO<sub>4</sub> (denomination of treatment group)</p></def></def-item><def-item><term id="jvim15094-li-0011">NaP</term><def id="jvim15094-li-0012"><p>group treated with NaH<sub>2</sub>PO<sub>4</sub> (denomination of treatment group)</p></def></def-item><def-item><term id="jvim15094-li-0013">Na<sub>2</sub>P</term><def id="jvim15094-li-0014"><p>group treated with Na<sub>2</sub>HPO<sub>4</sub> (denomination of treatment group)</p></def></def-item><def-item><term id="jvim15094-li-0015">P</term><def id="jvim15094-li-0016"><p>phosphorus</p></def></def-item><def-item><term id="jvim15094-li-0017">Pi</term><def id="jvim15094-li-0018"><p>phosphate</p></def></def-item><def-item><term id="jvim15094-li-0019">[Pi]</term><def id="jvim15094-li-0020"><p>concentration of phosphate</p></def></def-item><def-item><term id="jvim15094-li-0021">Pi&#x02010;C<sub>max</sub></term><def id="jvim15094-li-0022"><p>peak concentration of plasma phosphate</p></def></def-item><def-item><term id="jvim15094-li-0023">Pi&#x02010;C<sub>max&#x02010;model</sub></term><def id="jvim15094-li-0024"><p>peak concentration of plasma phosphate derived from a model</p></def></def-item><def-item><term id="jvim15094-li-0025">&#x00394;Pi&#x02010;C<sub>max</sub></term><def id="jvim15094-li-0026"><p>peak concentration of plasma phosphate increment</p></def></def-item><def-item><term id="jvim15094-li-0027">&#x00394;Pi&#x02010;C<sub>max&#x02010;model</sub></term><def id="jvim15094-li-0028"><p>peak concentration of plasma phosphate increment derived from a model</p></def></def-item><def-item><term id="jvim15094-li-0029">Pi&#x02010;T<sub>max</sub></term><def id="jvim15094-li-0030"><p>time to peak concentration of plasma phosphate</p></def></def-item><def-item><term id="jvim15094-li-0031">Pi&#x02010;T<sub>max&#x02010;model</sub></term><def id="jvim15094-li-0032"><p>time to peak concentration of plasma phosphate derived from a model</p></def></def-item><def-item><term id="jvim15094-li-0033">[TP]</term><def id="jvim15094-li-0034"><p>total protein concentration</p></def></def-item></def-list><sec id="jvim15094-sec-0006"><label>1</label><title>INTRODUCTION</title><p>Hypophosphatemia in dairy cows is thought to be associated with an increased risk of disease and impaired productivity particularly in early lactation.<xref rid="jvim15094-bib-0001" ref-type="ref">1</xref> It not only has been linked to decreased feed intake and productivity but is also believed to cause or contribute to periparturient conditions of the dairy cow such as the downer cow syndrome or postparturient hemoglobinuria.<xref rid="jvim15094-bib-0002" ref-type="ref">2</xref>, <xref rid="jvim15094-bib-0003" ref-type="ref">3</xref> The incidence of periparturient hypophosphatemia even in clinically healthy dairy cows is considerable. Metabolic profiling studies reported incidences of subnormal plasma phosphate concentrations ([Pi]) on the day of calving of above 50% and of 10%&#x02010;15% in the first two weeks of lactation.<xref rid="jvim15094-bib-0001" ref-type="ref">1</xref> The relevance of this periparturient hypophosphatemia remains disputed as it is frequently not associated with clinical signs such as recumbency and postparturient hemoglobinuria. It is the reason for which phosphorus (P) supplementation is recommended and practiced particularly in fresh cows.<xref rid="jvim15094-bib-0002" ref-type="ref">2</xref>, <xref rid="jvim15094-bib-0004" ref-type="ref">4</xref>, <xref rid="jvim15094-bib-0005" ref-type="ref">5</xref>
</p><p>Treatment recommendations published over the past decades often favor IV bolus administration of solutions containing phosphate (Pi) salts.<xref rid="jvim15094-bib-0002" ref-type="ref">2</xref>, <xref rid="jvim15094-bib-0006" ref-type="ref">6</xref>, <xref rid="jvim15094-bib-0007" ref-type="ref">7</xref>, <xref rid="jvim15094-bib-0008" ref-type="ref">8</xref> This approach however has raised concerns for several reasons. First in most countries of the world there are no commercial Pi&#x02010;containing solutions available that are labeled for the parenteral use in farm animals, making this approach an off&#x02010;label treatment. Products containing P in a form different and not convertible to Pi seem to be unsuitable for the correction of hypophosphatemia.<xref rid="jvim15094-bib-0001" ref-type="ref">1</xref>, <xref rid="jvim15094-bib-0004" ref-type="ref">4</xref> Secondly bolus infusion of Pi&#x02010;salt solutions results in a pronounced but short lived increase of plasma [Pi] above the reference range.<xref rid="jvim15094-bib-0006" ref-type="ref">6</xref> The poor solubility of Pi may result in complexing of Pi with divalent cations such as calcium or magnesium in plasma thereby causing a decline of the plasma calcium ([Ca]) and magnesium concentration ([Mg]), which presents a concern particularly in early lactation.<xref rid="jvim15094-bib-0002" ref-type="ref">2</xref>, <xref rid="jvim15094-bib-0009" ref-type="ref">9</xref> Thirdly the plasma [Pi] returns to baseline values within two to three hours after administration, making this treatment unsuitable to be used as stand&#x02010;alone treatment of hypophosphatemia.<xref rid="jvim15094-bib-0006" ref-type="ref">6</xref>
</p><p>Oral treatment of P&#x02010;depleted cows with Pi salts slightly delays onset of action when compared with IV treatment but the treatment is easy to administer and has as an effect lasting for 12&#x02013;24 hours.<xref rid="jvim15094-bib-0006" ref-type="ref">6</xref>, <xref rid="jvim15094-bib-0009" ref-type="ref">9</xref>, <xref rid="jvim15094-bib-0010" ref-type="ref">10</xref> Currently, a variety of Pi&#x02010;containing salts are recommended and used for the oral treatment of hypophosphatemia in cattle, but studies comparing these salts in their efficacy to correct hypophosphatemia are scant.<xref rid="jvim15094-bib-0001" ref-type="ref">1</xref>, <xref rid="jvim15094-bib-0002" ref-type="ref">2</xref>, <xref rid="jvim15094-bib-0008" ref-type="ref">8</xref> Therefore, the objective of this study was to compare different Pi&#x02010;salts commonly used in the field in their treatment efficacy for the correction of hypophosphatemia in dairy cows. The salts to be compared were monosodium dihydrogen phosphate (NaH<sub>2</sub>PO<sub>4</sub>), disodium monohydrogen phosphate (Na<sub>2</sub>HPO<sub>4</sub>), and magnesium phosphate (MgHPO<sub>4</sub>). We hypothesized that the efficacy for the correction of hypophosphatemia of these salts is primarily driven by their solubility characteristics. We therefore anticipated most rapid and pronounced effects for the most soluble NaH<sub>2</sub>PO<sub>4</sub> followed by Na<sub>2</sub>HPO<sub>4</sub> while a weaker and more delayed effect was expected for the poorly soluble MgHPO<sub>4</sub>.</p></sec><sec id="jvim15094-sec-0007"><label>2</label><title>MATERIALS AND METHODS</title><sec id="jvim15094-sec-0008"><label>2.1</label><title>Animals, housing, and feeding</title><p>The national and institutional guidelines for the care and use of experimental animals were followed and all experimental procedures were approved by the Utrecht University Institutional Animal Care and Use Committee (AVD108002016616).</p><p>Twelve clinically healthy Holstein Friesian cows in their fourth week of lactation were used for this study. Cows were between 3 and 6.5 years old and in their second to fifth lactation. All animals were healthy on the basis of physical examination despite of pronounced hypophosphatemia. Cows were housed in tie&#x02010;stalls with rubber bedding covered with saw dust in a temperature controlled environment.</p><p>Prior and during the experimental treatment enrolled cows were fed a Total Mixed Ration that was markedly phosphorus deficient, but that otherwise met currently used nutrient recommendations for dry and lactating dairy cows for a period of &#x0223c;8 weeks.<xref rid="jvim15094-bib-0011" ref-type="ref">11</xref> The dry cow ration that was offered for 4 weeks before the expected calving date contained &#x0223c;0.13% P in DM and the ration fed after calving contained &#x0223c;0.18% P in DM. The dietary P content was thus &#x0223c;50% below requirement during the late dry period and at least 40% below the recommended daily dietary supply after parturition.<xref rid="jvim15094-bib-0011" ref-type="ref">11</xref> Cows were fed and milked twice daily between 0600 and 0700 hours and 1800 and 1900 hours. The daily milk yield during the experimental treatment period ranged between 25 and 32 kg/day, daily feed intake ranged between 13 and 18 kg DM.</p></sec><sec id="jvim15094-sec-0009"><label>2.2</label><title>Experimental study</title><p>All cows received a sham treatment serving as control and were thereafter assigned to 1 of 3 experimental treatments by randomization. The wash&#x02010;out period between control and treatment was between 24 and 48 hours. Treatments consisted in a single oral administration of either plain water (sham treatment, group C, n&#x02009;=&#x02009;12) or the equivalent of 60 g P in the form of monosodium dihydrogen phosphate (302 g NaH<sub>2</sub>PO<sub>4</sub> &#x000d7; 2H<sub>2</sub>O, group NaP, n&#x02009;=&#x02009;4), disodium monohydrogen phosphate (345 g Na<sub>2</sub>HPO<sub>4</sub> &#x000d7; 2H<sub>2</sub>O, group Na<sub>2</sub>P, n&#x02009;=&#x02009;4) or magnesium hydrogen phosphate (338 g MgHPO<sub>4</sub> &#x000d7; 3H<sub>2</sub>O, group MgP, n&#x02009;=&#x02009;4). The salt was dissolved in 2 L of warm (&#x0223c;38&#x000b0;C) water and was administered by orogastric tube. Treatments were administered at standardized times between 0800 and 0830 hours. Sham treatment always preceded the experimental treatment. This approach was used because of the high individual variability of the treatment effect of PO administered Pi observed in earlier studies and the resulting difficulty to determine an adequate wash&#x02010;out period for the treatment. For blood sampling a 16 G catheter (Angiocath; Becton Dickinson, Heidelberg, Germany) connected to an extension set (Discofix C&#x02010;3, 10 cm; Braun Melsungen AG, Melsungen, Germany) was placed aseptically in a jugular vein the evening before the sham treatment.</p><p>Blood samples were collected immediately before treatment or sham administration (0) and again 30, 60, 90, 120, 180, 240, 300, 420, 720, and 1440 minutes after treatment. Blood was collected in 10 mL tubes containing lithium heparin as anticoagulant and kept at room temperature until processed. Samples were centrifuged within 10 min at 1600<italic>g</italic> for 15 minutes. Plasma was then harvested and stored at &#x02212;20&#x000b0;C until analyzed.</p></sec><sec id="jvim15094-sec-0010"><label>2.3</label><title>Biochemical analysis</title><p>The plasma [Pi], [Mg], and [Ca] were analyzed photometrically (ammonium molybdate, xylidyl blue, and Arsenazo III, respectively) on an automated analyzer (ABX Pentra 400; Horiba, Europe GmbH, Langenhagen, Germany). Total protein concentration ([TP]) was measured by refractometry using a temperature corrected refractometer.</p></sec><sec id="jvim15094-sec-0011"><label>2.4</label><title>Data analysis</title><p>For each animal, the maximum plasma [Pi] (Pi&#x02010;<italic>C</italic>
<sub>max</sub>) and the time to maximum plasma [Pi] (Pi&#x02010;<italic>T</italic>
<sub>max</sub>) were derived from its individual concentration&#x02009;&#x02212;&#x02009;time plot. The area under the curve of plasma [Pi] (AUC&#x02010;Pi) was calculated using the trapezoidal rule. The peak increment of plasma [Pi] was determined for each study animal by subtracting the baseline plasma [Pi] from the peak concentration of the electrolyte in question (&#x00394;Pi&#x02010;<italic>C</italic>
<sub>max</sub>). The same approach was used for [Mg] in animals of group MgP.</p><p>Plasma [Pi] at <italic>T<sub>i</sub></italic> was furthermore corrected for the change in plasma [TP] on a percent basis occurring between <italic>T</italic>
<sub>0</sub> and <italic>T<sub>i</sub></italic> as described earlier.<xref rid="jvim15094-bib-0012" ref-type="ref">12</xref> This approach was used to assess changes of plasma volume that may have occurred during the observation and may have affected the plasma [Pi] or [Mg].</p><p>To improve the precision of the estimation of &#x00394;Pi&#x02010;<italic>C</italic>
<sub>max</sub> and Pi&#x02010;<italic>T</italic>
<sub>max</sub> the plasma [Pi] for the treatment curves were modeled as log&#x02010;normal distribution such that <italic>f</italic>&#x02009;=&#x02009;<italic>y</italic>0&#x02009;+&#x02009;<italic>y</italic>&#x02022;<italic>e</italic>
<sup>&#x02212;0,5</sup>*<sup>(ln(</sup>
<sup><italic>x</italic></sup>
<sup>/</sup>
<sup><italic>x</italic></sup>
<sup>0)/</sup>
<sup><italic>b</italic></sup>
<sup>)&#x02009;^&#x02009;2)/</sup>
<sup><italic>x</italic></sup> using a plotting software package (Sigma Plot 12.5; Systat Software, San Jose, California). &#x00394;Pi&#x02010;<italic>C</italic>
<sub>max&#x02010;model</sub> and Pi&#x02010;<italic>T</italic>
<sub>max&#x02010;model</sub> were then derived from the respective functions for each treatment group.</p></sec><sec id="jvim15094-sec-0012"><label>2.5</label><title>Statistical analysis</title><p>Results are expressed as mean and SD or as median and interquartile range (IQR) for variables that were not normally distributed. Normality of distribution was checked by Shapiro&#x02010;Wilk's test for normality distribution and by checking normal probability plots. Log transformations were used wherever appropriate to obtain normal distribution. Repeated measurements ANOVAs were conducted to determine treatment, time, and interaction of time and treatment effects using an autoregressive model with Cow ID as subject. Post hoc tests were used whenever <italic>F</italic>&#x02010;test was significant. Bonferroni&#x02010;corrected <italic>P</italic> values were used and a <italic>P</italic>&#x02009;&#x0003c;&#x02009;.05 was considered statistically significant. A&#x000a0;statistical software package was used for all analyses (SAS 9.2; SAS Institute, Cary, North Carolina).</p></sec></sec><sec id="jvim15094-sec-0013"><label>3</label><title>RESULTS</title><p>All cows tolerated the assigned oral treatment well and remained healthy without any apparent adverse effects.</p><p>The plasma [Pi]&#x02010;time curves stratified by group are presented in Figure <xref rid="jvim15094-fig-0001" ref-type="fig">1</xref>. All cows included in the study presented pronounced hypophosphatemia immediately before treatment (NaP: 1.27 mg/dL [0.41 mmol/L], Na<sub>2</sub>P: 1.38 mg/dL [0.45 mmol/L], MgP: 1.44 mg/dL [0.47 mmol/L], C: 1.30 mg/dL [0.42 mmol/L]), which is notably beneath reference range of 4&#x02013;8 mg/dL or 1.4&#x02010;2.6 mmol/L.<xref rid="jvim15094-bib-0013" ref-type="ref">13</xref> Baseline plasma [Pi] did not differ between groups.</p><fig fig-type="Figure" xml:lang="en" id="jvim15094-fig-0001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Plasma phosphorus concentration&#x02010;time curve (median and IQR) stratified by treatment groups: group NaP (treatment with NaH<sub>2</sub>PO<sub>4</sub>, solid line; n&#x02009;=&#x02009;4), group Na<sub>2</sub>P (treatment with Na<sub>2</sub>HPO<sub>4,</sub> dashed dotted line; n&#x02009;=&#x02009;4), group MgP (treatment with MgHPO<sub>4</sub>, dotted line; n&#x02009;=&#x02009;4), and group C (control group, dashed line; n&#x02009;=&#x02009;12). Time points marked with* differ significantly from <italic>T</italic>
<sub>0</sub>. Values marked with different lowercase letters at a specific time point differ significantly between groups (<italic>P</italic>&#x02009;&#x0003c;&#x02009;.05; Bonferroni corrected). Data of groups NaP and MgP are slightly offset with respect to time to improve readability. Reference range for plasma phosphorus in cattle: 4&#x02013;8 mg/dL.<sup>13</sup> C, control, MgP, treatment with MgHPO<sub>4</sub>, NaP, treatment with NaH<sub>2</sub>PO<sub>4</sub>, Na<sub>2</sub>P, treatment with Na<sub>2</sub>HPO<sub>4</sub>
</p></caption><graphic id="nlm-graphic-1" xlink:href="JVIM-32-1253-g001"/></fig><p>The ANOVA revealed a significant treatment effect, with all treatment groups differing from control and MgP differing from NaP and Na<sub>2</sub>P. Although the plasma [Pi] in group NaP was numerically higher than in Na<sub>2</sub>P at various time points the difference was not significant at any time. Time effects were apparent in all groups except control.</p><p>The plasma [Pi] tended to increase within 30 minutes of treatment in groups NaP and Na<sub>2</sub>P with significantly increased values relative to baseline 60 minutes after treatment (NaP: <italic>P =</italic> .0044; Na<sub>2</sub>P: <italic>P =</italic> .0077<italic>)</italic>. The Pi&#x02010;<italic>T</italic>
<sub>max</sub> was 420 and 360 minutes after treatment with a peak increment of 5.33 mg/dL (1.72 mmol/L) and 4.30 mg/dL (1.39 mmol/L) in group NaP and Na<sub>2</sub>P, respectively (Table <xref rid="jvim15094-tbl-0001" ref-type="table-wrap">1</xref>). The plasma [Pi]&#x02010;time curve of group MgP revealed a very flat increase with values differing from baseline only after 300 minutes and a Pi&#x02010;<italic>T</italic>
<sub>max</sub> of 860 minutes with a maximum plasma [Pi] increment of 3.19 mg/dL (1.03 mmol/L, Table <xref rid="jvim15094-tbl-0001" ref-type="table-wrap">1</xref>). As expected no time effect on plasma [Pi] was observed in the control group. The median plasma [Pi] reached the reference range between 120 and 180 minutes after treatment in groups NaP and Na<sub>2</sub>P and after 720 minutes in group MgP. The plasma [Pi] remained markedly increased compared with baseline values until the end of the observation period at 24 hours post treatment in all three treatment groups.</p><table-wrap id="jvim15094-tbl-0001" xml:lang="en" orientation="portrait" position="float"><label>Table 1</label><caption><p>Median and IQR of peak increment of plasma Pi concentrations (&#x00394;Pi&#x02010;<italic>C</italic>
<sub>Max</sub>), time to peak increment of plasma Pi concentration (&#x00394;Pi&#x02010;<italic>T</italic>
<sub>Max</sub>), and area under the concentration&#x02010;time curve of plasma Pi concentration increment (&#x00394;Pi&#x02010;AUC) stratified by group</p></caption><table frame="hsides" rules="groups"><col style="border-bottom:solid 1px #000000; border-right:solid 1px #000000" width="80pt" span="1"/><col style="border-bottom:solid 1px #000000; border-right:solid 1px #000000" width="80pt" span="1"/><col style="border-bottom:solid 1px #000000; border-right:solid 1px #000000" width="80pt" span="1"/><col style="border-bottom:solid 1px #000000; border-right:solid 1px #000000" width="80pt" span="1"/><col style="border-bottom:solid 1px #000000; border-right:solid 1px #000000" width="80pt" span="1"/><col style="border-bottom:solid 1px #000000; border-right:solid 1px #000000" width="80pt" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1"/><th align="left" valign="bottom" rowspan="1" colspan="1"/><th align="left" valign="bottom" rowspan="1" colspan="1">C</th><th align="left" valign="bottom" rowspan="1" colspan="1">MgP</th><th align="left" valign="bottom" rowspan="1" colspan="1">NaP</th><th align="left" valign="bottom" rowspan="1" colspan="1">Na<sub>2</sub>P</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x00394;Pi&#x02010;<italic>C</italic>
<sub>Max</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1">mg/dL</td><td align="left" valign="top" rowspan="1" colspan="1">0.06<sup>a</sup> [0.03&#x02013;0.25]</td><td align="left" valign="top" rowspan="1" colspan="1">3.19<sup>b</sup> [2.11&#x02013;4.04]</td><td align="left" valign="top" rowspan="1" colspan="1">5.33<sup>b</sup> [5.26&#x02013;5.35]</td><td align="left" valign="top" rowspan="1" colspan="1">4.3<sup>b</sup> [3.59&#x02013;4.68]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Pi&#x02010;<italic>T</italic>
<sub>Max</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1">min</td><td align="left" valign="top" rowspan="1" colspan="1">300 [135&#x02013;1080]</td><td align="left" valign="top" rowspan="1" colspan="1">1440 [1080&#x02013;1440]</td><td align="left" valign="top" rowspan="1" colspan="1">420 [420&#x02013;570]</td><td align="left" valign="top" rowspan="1" colspan="1">360 [270&#x02013;420]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Pi&#x02010;AUC</td><td align="left" valign="top" rowspan="1" colspan="1">mg*h/L</td><td align="left" valign="top" rowspan="1" colspan="1">0.68<sup>a</sup> [&#x02013;0.68&#x02010;3.5]</td><td align="left" valign="top" rowspan="1" colspan="1">54.17<sup>b</sup> [37.54&#x02013;66.96]</td><td align="left" valign="top" rowspan="1" colspan="1">93.48<sup>c</sup> [82.07&#x02013;101.04]</td><td align="left" valign="top" rowspan="1" colspan="1">78.94<sup>a,b</sup> [74.73&#x02013;85.97]</td></tr></tbody></table><table-wrap-foot><fn id="jvim15094-note-0002"><p>Values with different superscript letters within a row were significantly different (<italic>P</italic>&#x02009;&#x0003c;&#x02009;.05, Bonferroni corrected). C, control, MgP, treatment with MgHPO<sub>4</sub>, NaP, treatment with NaH<sub>2</sub>PO<sub>4</sub>, Na<sub>2</sub>P, treatment with Na<sub>2</sub>HPO<sub>4</sub>.</p></fn></table-wrap-foot></table-wrap><p>Analysis of the protein corrected plasma [Pi] and comparison with uncorrected plasma [Pi] did not reveal any effect attributable to plasma volume changes (data not shown).</p><p>Table <xref rid="jvim15094-tbl-0001" ref-type="table-wrap">1</xref> summarizes the peak increment of plasma [Pi] (Pi&#x02010;&#x00394;<italic>C</italic>
<sub>max</sub>), Pi&#x02010;<italic>T</italic>
<sub>max</sub>, and the AUC&#x02010;Pi, values determined from the modeled plasma [Pi]&#x02010;time curves are shown in Table <xref rid="jvim15094-tbl-0002" ref-type="table-wrap">2</xref>. The AUC&#x02010;Pi was the largest in group NaP but differed only numerically from group Na<sub>2</sub>P. The AUC&#x02010;Pi of group MgP was 50% of group NaP.</p><table-wrap id="jvim15094-tbl-0002" xml:lang="en" orientation="portrait" position="float"><label>Table 2</label><caption><p>Peak increments of plasma Pi concentrations (&#x00394;Pi&#x02010;<italic>C</italic>
<sub>Max&#x02010;model</sub>) and time to peak increments of plasma Pi concentrations (Pi&#x02010;<italic>T</italic>
<sub>Max&#x02010;model</sub>) derived from log normal distribution models (<italic>f</italic>&#x02009;=&#x02009;<italic>y</italic>0&#x02009;+&#x02009;<italic>y</italic>&#x02022;e <sup>&#x02212;0,5*(ln(</sup>
<sup><italic>x</italic></sup>
<sup>/</sup>
<sup><italic>x</italic></sup>
<sup>0)/</sup>
<sup><italic>b</italic></sup>
<sup>)&#x02009;^&#x02009;2)/</sup>
<sup><italic>x</italic></sup>) developed for each treatment group</p></caption><table frame="hsides" rules="groups"><col style="border-bottom:solid 1px #000000; border-right:solid 1px #000000" width="80pt" span="1"/><col style="border-bottom:solid 1px #000000; border-right:solid 1px #000000" width="80pt" span="1"/><col style="border-bottom:solid 1px #000000; border-right:solid 1px #000000" width="80pt" span="1"/><col style="border-bottom:solid 1px #000000; border-right:solid 1px #000000" width="80pt" span="1"/><col style="border-bottom:solid 1px #000000; border-right:solid 1px #000000" width="80pt" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1"/><th align="left" valign="bottom" rowspan="1" colspan="1"/><th align="left" valign="bottom" rowspan="1" colspan="1">MgP</th><th align="left" valign="bottom" rowspan="1" colspan="1">NaP</th><th align="left" valign="bottom" rowspan="1" colspan="1">Na<sub>2</sub>P</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x00394;Pi&#x02010;<italic>C</italic>
<sub>Max&#x02010;model</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1">mg/dL</td><td align="left" valign="top" rowspan="1" colspan="1">3.31</td><td align="left" valign="top" rowspan="1" colspan="1">4.99</td><td align="left" valign="top" rowspan="1" colspan="1">4.21</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Pi&#x02010;<italic>T</italic>
<sub>Max&#x02010;model</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1">min</td><td align="left" valign="top" rowspan="1" colspan="1">860</td><td align="left" valign="top" rowspan="1" colspan="1">445</td><td align="left" valign="top" rowspan="1" colspan="1">460</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Goodness of fit</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>R</italic>
<sup>2</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">0.997</td><td align="left" valign="top" rowspan="1" colspan="1">0.981</td><td align="left" valign="top" rowspan="1" colspan="1">0.991</td></tr></tbody></table><table-wrap-foot><fn id="jvim15094-note-0003"><p>Goodness of fit characterized by <italic>R</italic>
<sup>2</sup> is given for the model developed for each of the three treatment groups. MgP, treatment with MgHPO<sub>4</sub>, NaP, treatment with NaH<sub>2</sub>PO<sub>4</sub>, Na<sub>2</sub>P, treatment with Na<sub>2</sub>HPO<sub>4</sub>.</p></fn></table-wrap-foot></table-wrap><p>Treatment with MgHPO<sub>4</sub> led to significant differences between group MgP and C (240&#x02013;720 minutes) and MgP and Na<sub>2</sub>P (420&#x02013;720 minutes) in plasma [Mg] (Figure <xref rid="jvim15094-fig-0002" ref-type="fig">2</xref>).</p><fig fig-type="Figure" xml:lang="en" id="jvim15094-fig-0002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Mean and SD of plasma magnesium concentration increments to baseline after treatment stratified by groups: group NaP (treatment with NaH<sub>2</sub>PO<sub>4</sub>, solid line; n&#x02009;=&#x02009;4), group Na<sub>2</sub>P (treatment with Na<sub>2</sub>HPO<sub>4,</sub> dashed dotted line; n&#x02009;=&#x02009;4), group MgP (treatment with MgHPO<sub>4</sub>, dotted line; n&#x02009;=&#x02009;4), and group C (control group, dashed line; n&#x02009;=&#x02009;12). Values marked with different lowercase letters at a specific time point differ significantly between groups (<italic>P</italic>&#x02009;&#x0003c;&#x02009;.05; Bonferroni corrected). Data of groups NaP and MgP are slightly offset with respect to time to improve readability. C, control, MgP, treatment with MgHPO<sub>4</sub>, NaP, treatment with NaH<sub>2</sub>PO<sub>4</sub>, Na<sub>2</sub>P, treatment with Na<sub>2</sub>HPO<sub>4</sub>
</p></caption><graphic id="nlm-graphic-3" xlink:href="JVIM-32-1253-g002"/></fig><p>Plasma [Ca] neither showed a significant time nor treatment effect (data not shown).</p></sec><sec id="jvim15094-sec-0014"><label>4</label><title>DISCUSSION</title><p>After oral treatment of markedly phosphorus deficient cows with 1 of 3 different Pi containing salts (NaH<sub>2</sub>PO<sub>4</sub>, Na<sub>2</sub>HPO<sub>4</sub>, or MgHPO<sub>4</sub>) the increase in plasma [Pi] was most pronounced in group NaP, followed by Na<sub>2</sub>P. The increment of plasma [Pi] in group MgP was considerably flatter and delayed in time. We suggest that solubility characteristics of the salts used plays a central part in oral availability for resorption.</p><p>The main objective of the present study was to compare the efficacy of different Pi containing salts for the treatment of hypophosphatemia in dairy cows. The addressed question is relevant as the expectation of an oral treatment with Pi&#x02010;salts to rapidly correct acute hypophosphatemia in cows is inherently different from the use of Pi&#x02010;salts used as feed additives to supplement P&#x02010;deficient diets. An oral treatment for the correction of hypophosphatemia that is suitable to replace or at least complement parenteral P&#x02010;supplementation should have a rapid onset of action and a sustained effect lasting for at least 24 hours. For example, earlier studies revealed that dicalcium phosphate, a salt widely used for the supplementation of P&#x02010;deficient ruminant rations, is poorly suited for the rapid correction of hypophosphatemia.<xref rid="jvim15094-bib-0006" ref-type="ref">6</xref>, <xref rid="jvim15094-bib-0009" ref-type="ref">9</xref> Another interesting observation is that the preference of different Pi containing salts varies by geographic regions for no apparent reason. While monosodium phosphate is widely used for the treatment of hypophosphatemia in the Americas, in Europe disodium phosphate is widely marketed for the oral treatment of cattle.<xref rid="jvim15094-bib-0002" ref-type="ref">2</xref>, <xref rid="jvim15094-bib-0005" ref-type="ref">5</xref>, <xref rid="jvim15094-bib-0014" ref-type="ref">14</xref>
</p><p>Baseline plasma [Pi] determined in this study were consistent with pronounced hypophosphatemia and without difference between treatment groups, confirming that the dietary P&#x02010;depletion protocol used before application of the experimental treatment was appropriate to induce hypophosphatemia. A rapid and sustained effect on the plasma [Pi] was observed for both sodium phosphate salts with significant effects detectable within 1 hour, peak concentrations occurring after six to seven hours and an effect sustained for over 24 hours (Figure <xref rid="jvim15094-fig-0001" ref-type="fig">1</xref> and Table <xref rid="jvim15094-tbl-0001" ref-type="table-wrap">1</xref>). In both groups, the low end of the reference range of plasma [Pi] was reached within 2&#x02013;3 hours and maintained for 24 hours after treatment. Differences between group NaP and Na<sub>2</sub>P were not significant suggesting a similar effect of NaH<sub>2</sub>PO<sub>4</sub> compared with Na<sub>2</sub>HPO<sub>4</sub>. This is remarkable as both salts differ considerably in their solubility characteristics. Na<sub>2</sub>HPO<sub>4</sub> has a relatively low solubility of 7.7 g/dL water<xref rid="jvim15094-bib-0015" ref-type="ref">15</xref> compared with NaH<sub>2</sub>PO<sub>4</sub> with 85 g/dL water at 20&#x000b0;C.<xref rid="jvim15094-bib-0016" ref-type="ref">16</xref> The low sample size of four animals per treatment group in this study likely resulted in insufficient statistical power to reveal the moderate difference between the treatments with NaH<sub>2</sub>PO<sub>4</sub> and Na<sub>2</sub>HPO<sub>4</sub>.</p><p>The treatment effect with NaH<sub>2</sub>PO<sub>4</sub> reported in this study differs from results of other studies conducted in cattle having used similar doses of NaH<sub>2</sub>PO<sub>4</sub>.<xref rid="jvim15094-bib-0009" ref-type="ref">9</xref>, <xref rid="jvim15094-bib-0010" ref-type="ref">10</xref> In these studies, a less pronounced effect on the plasma [Pi] was reported with increases in the range of only 3 mg/dL (1 mmol/L), while peak concentrations were reached sooner, between 4 and 5 hours after treatment. It is probable that this difference between studies is attributable to the much more pronounced hypophosphatemia in this study that was achieved through a considerably longer duration of dietary P&#x02010;depletion. The degree of stimulation of enteral Pi&#x02010;absorption is associated with the degree of P&#x02010;deprivation.<xref rid="jvim15094-bib-0017" ref-type="ref">17</xref> Stronger stimulation of enteral P uptake is therefore likely to have contributed to higher peak plasma [Pi] values and could also explain delayed peaks through prolonged absorption.</p><p>Discrepancies between this and other studies also exist for the effect of Na<sub>2</sub>HPO<sub>4</sub>. An older study used Na<sub>2</sub>HPO<sub>4</sub> to treat dairy cows but reported no effect.<xref rid="jvim15094-bib-0008" ref-type="ref">8</xref> The lack of effect of oral Na<sub>2</sub>HPO<sub>4</sub> reported in that study might however be attributable to the use of dairy cows that were not P&#x02010;deprived, which might have resulted in considerably lower absorption rates of dietary P.</p><p>The oral treatment with MgHPO<sub>4</sub> in this study was markedly less effective in the timely correction of hypophosphatemia. A significant effect on the plasma [Pi] was apparent only five hours after treatment, with peak concentrations occurring 14 hours after treatment and peak increments of plasma [Pi] that were considerably lower than in the groups treated with sodium phosphate salts. We attribute this protracted effect on the plasma [Pi] to the low solubility of MgHPO<sub>4</sub> (0.025 g/dL water at 20&#x000b0;C).<xref rid="jvim15094-bib-0018" ref-type="ref">18</xref> MgHPO<sub>4</sub> has been reported to precipitate to quanite (NH<sub>4</sub>MgHPO<sub>4</sub>) in the rumen of sheep, a reaction if also occurring in cattle could have further contributed to impaired bioavailability of this compound.<xref rid="jvim15094-bib-0019" ref-type="ref">19</xref> There are similar poor effects on the plasma [Pi] for dicalcium phosphates another phosphate salt with very low solubility in water.<xref rid="jvim15094-bib-0006" ref-type="ref">6</xref>, <xref rid="jvim15094-bib-0009" ref-type="ref">9</xref> Both, dicalcium phosphate and MgHPO<sub>4</sub> must be considered unsuitable for rapid correction of hypophosphatemia through oral treatment as drench or bolus and are probably more suited as feed additives to supplement P&#x02010;deficient diets on a long term.</p><p>Treatment with MgHPO<sub>4</sub> in this study led to increases in plasma [Mg] in the range of 0.3 mg/dL (0.12 mmol/L) compared with the group C. It should be noted that control and treatment groups had plasma [Mg] within the reference range at all times (1.7&#x02010;3.0 mg/dL; 0.7&#x02010;1.23 mmol/L).<xref rid="jvim15094-bib-0013" ref-type="ref">13</xref> The delayed effect on plasma [Mg] matches the slope of the plasma [Pi] in the animals treated with MgHPO<sub>4</sub>, which corroborates the assumption that the absorption of this salt is hampered by its very limited solubility and possibly precipitates in ruminal fluid.<xref rid="jvim15094-bib-0019" ref-type="ref">19</xref>
</p><p>Supplementation of large oral doses of P was reported to impair the apparent absorption of Mg in animals that were not P&#x02010;deficient.<xref rid="jvim15094-bib-0020" ref-type="ref">20</xref>, <xref rid="jvim15094-bib-0021" ref-type="ref">21</xref> It has thus been suggested that in states of limited availability of dietary Mg excessive supply of oral P might increase the risk for hypomagnesemic tetany.<xref rid="jvim15094-bib-0020" ref-type="ref">20</xref> In contrast, in states of low dietary P&#x02010;supply it was found that the supplementation of P can enhance transruminal Mg&#x02010;absorption in isolated rumen of sheep.<xref rid="jvim15094-bib-0022" ref-type="ref">22</xref> In this study, treatment with sodium phosphate salts had no effect on the plasma [Mg], which suggests that a single treatment with oral monosodium&#x02010; or disodium phosphate does not cause a relevant disturbance of the Mg balance in treated animals. This is in agreement with an earlier study investigating the effect of a single oral dose of different phosphate salts in hypophosphatemic dairy cows.<xref rid="jvim15094-bib-0010" ref-type="ref">10</xref>
</p></sec><sec id="jvim15094-sec-0015"><label>5</label><title>CONCLUSIONS</title><p>In conclusion a single oral treatment with NaH<sub>2</sub>PO<sub>4</sub> or Na<sub>2</sub>HPO<sub>4</sub> providing the equivalent of 60 g P is adequate for the timely correction of hypophosphatemia in cattle. The treatment has a rapid onset of action and a sustained effect. Oral administration of MgHPO<sub>4</sub> has a considerably protracted effect on the plasma [Pi] and is therefore not recommended to be used as drench or bolus in animals requiring rapid correction of blood [Pi].</p></sec><sec id="jvim15094-sec-0017"><title>CONFLICT OF INTEREST DECLARATION</title><p>Authors declare no conflict of interest.</p></sec><sec id="jvim15094-sec-0018"><title>OFF&#x02010;LABEL ANTIMICROBIAL DECLARATION</title><p>Authors declare no off&#x02010;label use of antimicrobials.</p></sec><sec id="jvim15094-sec-0019"><title>INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC) OR OTHER APPROVAL DECLARATION</title><p>The national and institutional guidelines for the care and use of experimental animals were followed and all experimental procedures were approved by the Utrecht University IACUC (AVD108002016616).</p></sec></body><back><ack id="jvim15094-sec-0016"><title>ACKNOWLEDGMENTS</title><p>The study reported here was conducted at the Department of Farm Animal Health, Utrecht University, Utrecht, the Netherlands. ZuivelNL, the organization of the Dutch dairy supply chain contributed to the funding of this study. The authors acknowledge the support of Aliphos, Rotterdam BV who provided the magnesium phosphate used in this study. They furthermore acknowledge the technical assistance of the caretakers of the Department of farm animal health, Utrecht University. This publication was supported by Deutsche Forschungsgemeinschaft and University of Veterinary Medicine Hannover, Foundation within the funding programme Open Access Publishing.</p></ack><ref-list content-type="cited-references"><title>REFERENCES</title><ref id="jvim15094-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="jvim15094-cit-0002">
<string-name>
<surname>Grunberg</surname>
<given-names>W.</given-names>
</string-name>
<article-title>Treatment of phosphorus balance disorders</article-title>. <source xml:lang="en">Vet Clin North Am Food Anim Pract.</source>
<year>2014</year>;<volume>30</volume>:<fpage>383</fpage>&#x02013;<lpage>408</lpage>.
<pub-id pub-id-type="pmid">24980728</pub-id></mixed-citation></ref><ref id="jvim15094-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="jvim15094-cit-0003">
<string-name>
<surname>Goff</surname>
<given-names>JP.</given-names>
</string-name>
<article-title>Treatment of calcium, phosphorus, and magnesium balance disorders</article-title>. <source xml:lang="en">Vet Clin North Am Food Anim Pract.</source>
<year>1999</year>;<volume>15</volume>:<fpage>619</fpage>&#x02013;<lpage>639</lpage>.
<pub-id pub-id-type="pmid">10573815</pub-id></mixed-citation></ref><ref id="jvim15094-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="jvim15094-cit-0004">
<string-name>
<surname>Ogawa</surname>
<given-names>E</given-names>
</string-name>, 
<string-name>
<surname>Kobayashi</surname>
<given-names>K</given-names>
</string-name>, 
<string-name>
<surname>Yoshiura</surname>
<given-names>N.</given-names>
</string-name>
<article-title>Bovine postparturient hemoglobinemia: hypophosphatemia and metabolic disorder in red blood cells</article-title>. <source xml:lang="en">Am J Vet Res.</source>
<year>1987</year>;<volume>48</volume>:<fpage>1300</fpage>&#x02013;<lpage>1303</lpage>.
<pub-id pub-id-type="pmid">3631722</pub-id></mixed-citation></ref><ref id="jvim15094-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="jvim15094-cit-0005">
<string-name>
<surname>Constable</surname>
<given-names>P.</given-names>
</string-name>
<article-title>Fluid and electrolyte therapy in ruminants</article-title>. <source xml:lang="en">Vet Clin North Am Food Anim Pract.</source>
<year>2003</year>;<volume>19</volume>:<fpage>557</fpage>&#x02013;<lpage>597</lpage>.
<pub-id pub-id-type="pmid">14608802</pub-id></mixed-citation></ref><ref id="jvim15094-bib-0005"><label>5</label><mixed-citation publication-type="miscellaneous" id="jvim15094-cit-0006">
<string-name>
<surname>Staufenbiel</surname>
<given-names>R</given-names>
</string-name>, 
<string-name>
<surname>Dallmeyer</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Horner</surname>
<given-names>S.</given-names>
</string-name> Hinweise zur Therapie des atypischen Festliegens. In: Gropp J, Ribbeck R, eds. Atypisches Festliegen beim Rind. Kongressband Internationaler Workshop. 2. Leipzig: Leipziger Tier&#x000e4;rztekongress; <year>2002</year>:288&#x02013;291.
</mixed-citation></ref><ref id="jvim15094-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="jvim15094-cit-0007">
<string-name>
<surname>Chen</surname>
<given-names>Y&#x02010;H</given-names>
</string-name>, 
<string-name>
<surname>Goff</surname>
<given-names>JP</given-names>
</string-name>, 
<string-name>
<surname>Horst</surname>
<given-names>RL.</given-names>
</string-name>
<article-title>Restoring normal blood phosphorus concentrations in hypophosphatemic cattle with sodium phosphate</article-title>. <source xml:lang="en">Vet Med.</source>
<year>1998</year>;<volume>4</volume>:<fpage>383</fpage>&#x02013;<lpage>386</lpage>.
</mixed-citation></ref><ref id="jvim15094-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="jvim15094-cit-0008">
<string-name>
<surname>Horner</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Staufenbiel</surname>
<given-names>R.</given-names>
</string-name>
<article-title>The influence of different therapeutic substances applieable for phosphat substitution on the concentration of phosphore in the blood</article-title>. <source xml:lang="en">Der Praktische Tierarzt.</source>
<year>2004</year>;<volume>85</volume>:<fpage>8</fpage>.
</mixed-citation></ref><ref id="jvim15094-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="jvim15094-cit-0009">
<string-name>
<surname>Horner</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Staufenbiel</surname>
<given-names>R.</given-names>
</string-name>
<article-title>About the effectiveness of orally or subcutaneous phosphorus substitution with cattle</article-title>. <source xml:lang="en">Der Praktische Tierarzt.</source>
<year>2004</year>;<volume>85</volume>:<fpage>7</fpage>.
</mixed-citation></ref><ref id="jvim15094-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="jvim15094-cit-0010">
<string-name>
<surname>Grunberg</surname>
<given-names>W</given-names>
</string-name>, 
<string-name>
<surname>Dobbelaar</surname>
<given-names>P</given-names>
</string-name>, 
<string-name>
<surname>Breves</surname>
<given-names>G.</given-names>
</string-name>
<article-title>Kinetics of phosphate absorption in lactating dairy cows after enteral administration of sodium phosphate or calcium phosphate salts</article-title>. <source xml:lang="en">Br J Nutr.</source>
<year>2013</year>;<volume>110</volume>:<fpage>1012</fpage>&#x02013;<lpage>1023</lpage>.
<pub-id pub-id-type="pmid">23544958</pub-id></mixed-citation></ref><ref id="jvim15094-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="jvim15094-cit-0011">
<string-name>
<surname>Idink</surname>
<given-names>MJ</given-names>
</string-name>, 
<string-name>
<surname>Grunberg</surname>
<given-names>W.</given-names>
</string-name>
<article-title>Enteral administration of monosodium phosphate, monopotassium phosphate and monocalcium phosphate for the treatment of hypophosphataemia in lactating dairy cattle</article-title>. <source xml:lang="en">Vet Rec.</source>
<year>2015</year>;<volume>176</volume>:<fpage>494</fpage>.
<pub-id pub-id-type="pmid">25721509</pub-id></mixed-citation></ref><ref id="jvim15094-bib-0011"><label>11</label><mixed-citation publication-type="book" id="jvim15094-cit-0012">
<collab collab-type="authors">NRC</collab>
. <source xml:lang="en">Nutrient Requirements of Dairy Cattle</source>. <edition>7th rev</edition> ed. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>National Academic Press</publisher-name>; <year>2001</year>.
</mixed-citation></ref><ref id="jvim15094-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="jvim15094-cit-0013">
<string-name>
<surname>Grunberg</surname>
<given-names>W</given-names>
</string-name>, 
<string-name>
<surname>Hartmann</surname>
<given-names>H</given-names>
</string-name>, 
<string-name>
<surname>Burfeind</surname>
<given-names>O</given-names>
</string-name>, Heuwieser W, Staufenbiel R. <article-title>Plasma potassium&#x02010;lowering effect of oral glucose, sodium bicarbonate, and the combination thereof in healthy neonatal dairy calves</article-title>. <source xml:lang="en">J Dairy Sci.</source>
<year>2011</year>;<volume>94</volume>:<fpage>5646</fpage>&#x02013;<lpage>5655</lpage>.
<pub-id pub-id-type="pmid">22032387</pub-id></mixed-citation></ref><ref id="jvim15094-bib-0013"><label>13</label><mixed-citation publication-type="book" id="jvim15094-cit-0014">
<string-name>
<surname>Constable</surname>
<given-names>PD</given-names>
</string-name>, 
<string-name>
<surname>Hinchliff</surname>
<given-names>KW</given-names>
</string-name>, 
<string-name>
<surname>Done</surname>
<given-names>SH</given-names>
</string-name>, 
<string-name>
<surname>Gr&#x000fc;nberg</surname>
<given-names>W.</given-names>
</string-name>
<source xml:lang="en">Veterinary medicine: A textbook of the diseases of cattle, horses, sheep, pigs, and goats</source>. <edition>11th ed.</edition> (Chapters 15, Diseases of the Musculoskeletal System; Chapter 17, Metabolic and Endocrine Diseases); <publisher-loc>St Louis, MO</publisher-loc>: <publisher-name>Elsevier Health Sciences</publisher-name>; <year>2017</year>:<fpage>1488</fpage>&#x02013;<lpage>1703</lpage>.
</mixed-citation></ref><ref id="jvim15094-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="jvim15094-cit-0015">
<string-name>
<surname>Braun</surname>
<given-names>U</given-names>
</string-name>, 
<string-name>
<surname>Dumelin</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Liesegang</surname>
<given-names>A</given-names>
</string-name>, Bleul U, H&#x000e4;ssig M. <article-title>Effect of intravenous calcium and oral sodium phosphate on electrolytes in cows with parturient paresis</article-title>. <source xml:lang="en">Vet Rec.</source>
<year>2007</year>;<volume>161</volume>:<fpage>490</fpage>&#x02013;<lpage>492</lpage>.
<pub-id pub-id-type="pmid">17921443</pub-id></mixed-citation></ref><ref id="jvim15094-bib-0015"><label>15</label><mixed-citation publication-type="miscellaneous" id="jvim15094-cit-0016">
<collab collab-type="authors">Wikipedia.org</collab>
. Saint Petersburg, FL: Wikimedia Foundation. <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Disodium_phosphate">https://en.wikipedia.org/wiki/Disodium_phosphate</ext-link>. Accessed October 5, 2017.
</mixed-citation></ref><ref id="jvim15094-bib-0016"><label>16</label><mixed-citation publication-type="miscellaneous" id="jvim15094-cit-0017">
<collab collab-type="authors">Wikipedia.org</collab>
. Saint Petersburg, FL: Wikimedia Foundation. <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Monosodium_phosphate">https://en.wikipedia.org/wiki/Monosodium_phosphate</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://de.wikipedia.org/wiki/Natriumdihydrogenphosphate">https://de.wikipedia.org/wiki/Natriumdihydrogenphosphate</ext-link>. Accessed October 5, 2017.
</mixed-citation></ref><ref id="jvim15094-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="jvim15094-cit-0018">
<string-name>
<surname>Horst</surname>
<given-names>RL.</given-names>
</string-name>
<article-title>Regulation of calcium and phosphorus homeostasis in the dairy cow</article-title>. <source xml:lang="en">J Dairy Sci.</source>
<year>1986</year>;<volume>69</volume>:<fpage>604</fpage>&#x02013;<lpage>616</lpage>.
<pub-id pub-id-type="pmid">3517093</pub-id></mixed-citation></ref><ref id="jvim15094-bib-0018"><label>18</label><mixed-citation publication-type="miscellaneous" id="jvim15094-cit-0019">
<collab collab-type="authors">Wikipedia.org</collab>
. Saint Petersburg, FL: Wikimedia Foundation. <ext-link ext-link-type="uri" xlink:href="https://de.wikipedia.org/wiki/Magnesiumhydrogenphosphat">https://de.wikipedia.org/wiki/Magnesiumhydrogenphosphat</ext-link>. Accessed October 5, 2017.
</mixed-citation></ref><ref id="jvim15094-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="jvim15094-cit-0020">
<string-name>
<surname>Axford</surname>
<given-names>RFE</given-names>
</string-name>, 
<string-name>
<surname>Hughes</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Evans</surname>
<given-names>RA.</given-names>
</string-name>
<article-title>Magnesium ammonium phosphate precipitation and its significance in sheep</article-title>. <source xml:lang="en">Proc Nutr Soc.</source>
<year>1982</year>;<volume>41</volume>:<fpage>85A</fpage>.
</mixed-citation></ref><ref id="jvim15094-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="jvim15094-cit-0021">
<string-name>
<surname>Schonewille</surname>
<given-names>JT</given-names>
</string-name>, 
<string-name>
<surname>Klooster</surname>
<given-names>AT</given-names>
</string-name>, 
<string-name>
<surname>Beynen</surname>
<given-names>AC.</given-names>
</string-name>
<article-title>High phosphorus intake depresses apparent magnesium absorption in pregnant heifers</article-title>. <source xml:lang="en">J Anim Physiol Anim Nutr.</source>
<year>1994</year>;<volume>71</volume>:<fpage>15</fpage>&#x02013;<lpage>21</lpage>.
</mixed-citation></ref><ref id="jvim15094-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="jvim15094-cit-0022">
<string-name>
<surname>Standish</surname>
<given-names>JF</given-names>
</string-name>, 
<string-name>
<surname>Ammerman</surname>
<given-names>CB</given-names>
</string-name>, 
<string-name>
<surname>Palmer</surname>
<given-names>AZ</given-names>
</string-name>, 
<string-name>
<surname>Simpson</surname>
<given-names>CF.</given-names>
</string-name>
<article-title>Influence of dietary iron and phosphorus on performance, tissue mineral composition and mineral absorption in steers</article-title>. <source xml:lang="en">J Anim Sci.</source>
<year>1971</year>;<volume>33</volume>:<fpage>171</fpage>&#x02013;<lpage>178</lpage>.
<pub-id pub-id-type="pmid">5571083</pub-id></mixed-citation></ref><ref id="jvim15094-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="jvim15094-cit-0023">
<string-name>
<surname>Beardsworth</surname>
<given-names>LJ</given-names>
</string-name>, 
<string-name>
<surname>Beardsworth</surname>
<given-names>PM</given-names>
</string-name>, 
<string-name>
<surname>Care</surname>
<given-names>AD.</given-names>
</string-name>
<article-title>The effect of ruminal phosphate concentration on the absorption of calcium, phosphorus and magnesium from the reticulo&#x02010;rumen of the sheep</article-title>. <source xml:lang="en">Br J Nutr.</source>
<year>1989</year>;<volume>61</volume>:<fpage>715</fpage>&#x02013;<lpage>723</lpage>.
<pub-id pub-id-type="pmid">2758020</pub-id></mixed-citation></ref></ref-list></back></article>